Common Mutations in Chinese Patients With NSCLC Linked With Treatment Outcomes, Disease Severity
January 20th 2022The frequency of several mutations that inhibit response to tyrosine kinase inhibitors and tend to lead to increased disease severity was elevated in Chinese patients with non-small cell lung cancer.
Read More
What We’re Reading: Licensing COVID-19 Pill; Pig-to-Human Transplants; Blood Tube Shortage
January 20th 2022Drug makers sign on to help produce Merck’s COVID-19 pill for developing countries; research shows promise for organ transplants from genetically modified pigs; blood sample collection tubes added to FDA list of shortages.
Read More
Model Could Help Screen NSCLC Patients Likely to Benefit From Anti–PD-L1 Immunotherapy
January 19th 2022A model developed by researchers in China could help identify patients with non–small cell lung cancer (NSCLC) most likely to benefit from anti– programmed death-ligand 1 (PD-L1) immunotherapy.
Read More
Polypharmacy Linked With Rehospitalization, Death Among Patients With HF
January 19th 2022An analysis conducted in Japan among patients with acute decompensated heart failure (HF) revealed excessive polypharmacy at hospital discharge is associated with an increased risk of mortality after 1 year.
Read More
Study: Which AI Model Is the Best at Detecting Early-Stage CKD?
January 19th 2022A study comparing 4 different artificial intelligence (AI) models found that some models were better than others at detecting early-stage chronic kidney disease (CKD), when patients do not experience visible symptoms.
Read More
Patients With Psoriatic Disease, Dermatologists Prefer Specialist-Led Care Model for CVD Prevention
January 19th 2022Patients with psoriatic disease and dermatologists reported their preferred strategies to improve cardiovascular disease risk management, with a specialist-led model of care touted by both groups.
Read More